🇺🇸 FDA
Patent

US 9206183

Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors

granted A61KA61K31/437A61K31/497

Quick answer

US patent 9206183 (Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors) held by Almirall, S.A. expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/437, A61K31/497, A61K31/4985, A61K31/506